ALFA Finder| Management target | Revenue 10.0% FY27 |
|---|
| Revenue growth | 23% consolidated revenue growth YoY in Q1FY27. |
|---|---|
| Margins | EBITDA margin up 40 bps to 20.7%; gross margins up 30 bps. |
| Demand visibility | Healthy domestic demand; some transient headwinds in international markets. |
| Management confidence | High; citing highest profit growth in 28 quarters. |
Growth
Revenue grew 23% YoY; EBITDA and PAT grew 25%. India business saw 11% volume and 21% revenue growth.
Outlook
Aims to cross INR 15,000Cr revenue in FY27. Target of 20% EBITDA growth and Vision 2030 of INR 20,000Cr revenue.
Risks
Persistent high inflation in Bangladesh; volatile global macro environment; rising crude and vegetable oil costs impacting Q2 margins.
Last quarter's promises, checked
Delivered
- Guided INR 15,000Cr revenue in FY27 → delivered 23% Q1 growth (On track = BEAT)
- Guided high-teen EBITDA growth → delivered 25% PAT growth (= BEAT)
- Guided Foods growth 20-25% → delivered 43% (= BEAT)
Partly delivered
- Guided 150 bps margin expansion for FY27 → delivered 40 bps in Q1 (= PARTIAL)
Earnings Call Transcript filed with BSE, NSE: MARICO. Summary written with AI assistance from the document.
Marico Ltd: key numbers
- Share price
- ₹907.45
- Market cap
- ₹1,17,987 Cr
- Revenue (annual)
- ₹13,611 Cr
- Net profit (annual)
- ₹1,762 Cr
- P/E (TTM)
- 58.5×Sector 41.3×
- Promoter holding
- 58.83%-0.08% QoQ
- FII holding
- 22.25%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Marico Ltd
All →Marico Acquisition Worth ₹35 Cr
Marico will acquire 51% of Bonorizon Consumer Ventures via primary subscription for up to Rs 35 crore in cash. Completion is expected within 90 days of signing definitive agreements.
- Value
- ₹35.00 Cr
- Execution
- Within 90 days from signing of definitive agreements
Marico Acquisition Worth ₹113.7 Cr
Marico bought a further 20% stake in Cosmix Wellness for Rs. 113.65 Crore cash. Its holding rises from 60% to 80%.
- Value
- ₹113.7 Cr
Marico Annual General Meeting
Marico seeks postal ballot approval to appoint Rohit Jawa as Independent Director from 1 January 2027 for five years. Remote e-voting ends 7 December 2026.
Marico Earnings Call Transcript: Key Takeaways
Strong Q2: revenue +13%, EBITA +27%, PAT +31%, EBITA margin 18.2%, helped by softer copra and mix. FY27 EBITDA guidance raised to mid-20s growth, while A&P spend rose 44%.
- Call
- Guides 13% growth
Marico Management Change
Marico's board appointed Mr. Rohit Jawa as Additional Independent Director for a five-year term. Shareholder approval will be sought via postal ballot.
Marico Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹3,897 Cr (+13%), EBITDA ₹709 Cr (+27%), PAT ₹550 Cr (+31%); volume-led growth with Foods and Premium Personal Care scaling.